Last 12 months
Inside the activity.
6 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 4 | 0 |
| Dec 2025 | 2 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 29, 2025 Filed Dec 30, 2025 10:05 UTC |
Luzon RonenDirector · Chief Executive Officer
|
PurchaseCommon Stock | 3,750 | $0.78 | $2,925.00 |
DisclosureSEC source: 0001493152-25-029521 · ownership.xml · nonDerivative · entry 1 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 293,085 F1 · price: The reported price is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.77 to $0.79 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 16:15 UTC |
Zimmerman GuyDirector
|
GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-028139 · ownership.xml · nonDerivative · entry 1 Zimmerman Guy · CIK 0001879643 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,500 F1 · shares: Restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan. F2 · shares: The restricted shares vest on December 31, 2025, subject to the Reporting Person's continued service to the Issuer as of such vesting date. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 16:15 UTC |
Elmaliah OrenChief Financial Officer
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-028140 · ownership.xml · nonDerivative · entry 1 Elmaliah Oren · CIK 0001713701 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,500 F1 · shares: Restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan. F2 · shares: The restricted shares vest in three equal annual installments, with 1/3 vesting on each of January 1, 2026, January 1, 2027 and January 1, 2028, subject to the Reporting Person's continued service to the Issuer as of each vesting date. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 16:15 UTC |
Pardo BillyCPO & COO
|
GrantCommon Stock | 215,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-028144 · ownership.xml · nonDerivative · entry 2 Pardo Billy · CIK 0001686858 · CPO & COO 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 289,335 F1 · shares: Restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan (the "Plan"). F4 · shares: 75,000 restricted shares vest in three equal annual installments, with 1/3 vesting on each of January 1, 2026, January 1, 2027 and January 1, 2028, subject to the Reporting Person's spouse continued service to the Issuer as of each vesting date. F5 · shares: Up to 125,000 restricted shares vest upon and subject to achievement of certain profit and business targets as set forth in the restricted stock agreement, subject to the Reporting Person's spouse continued service to the Issuer as of each vesting date. F6 · shares: 15,000 restricted shares vest on December 31, 2025, subject to the Reporting Person's spouse continued service to the Issuer as of such vesting date. F7 · ownership.nature: Common stock beneficially owned by Reporting Person's Spouse (Director and Chief Executive Officer Ronen Luzon) under the Plan. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 16:15 UTC |
Pardo BillyCPO & COO
|
GrantCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-028144 · ownership.xml · nonDerivative · entry 1 Pardo Billy · CIK 0001686858 · CPO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,750 F1 · shares: Restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan (the "Plan"). F2 · shares: 40,000 restricted shares vest in three equal annual installments, with 1/3 vesting on each of January 1, 2026, January 1, 2027 and January 1, 2028, subject to the Reporting Person's continued service to the Issuer as of each vesting date. F3 · shares: Up to 20,000 restricted shares vest upon and subject to achievement of certain profit and business targets as set forth in the restricted stock agreement, subject to the Reporting Person's continued service to the Issuer as of each vesting date. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 16:15 UTC |
Luzon RonenDirector · Chief Executive Officer
|
GrantCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-028147 · ownership.xml · nonDerivative · entry 2 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 79,750 F1 · shares: Restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan (the "Plan"). F5 · shares: 40,000 restricted shares vest in three equal annual installments, with 1/3 vesting on each of January 1, 2026, January 1, 2027 and January 1, 2028, subject to the Reporting Person's spouse continued service to the Issuer as of each vesting date. F6 · shares: Up to 20,000 restricted shares vest upon and subject to achievement of certain profit and business targets as set forth in the restricted stock agreement, subject to the Reporting Person's spouse continued service to the Issuer as of each vesting date. F7 · ownership.nature: Common stock beneficially owned by Reporting Perosn's Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo) under the Plan. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 16:15 UTC |
Luzon RonenDirector · Chief Executive Officer
|
GrantCommon Stock | 215,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-028147 · ownership.xml · nonDerivative · entry 1 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 289,335 F1 · shares: Restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan (the "Plan"). F2 · shares: 75,000 restricted shares vest in three equal annual installments, with 1/3 vesting on each of January 1, 2026, January 1, 2027 and January 1, 2028, subject to the Reporting Person's continued service to the Issuer as of each vesting date. F3 · shares: Up to 125,000 restricted shares vest upon and subject to achievement of certain profit and business targets as set forth in the restricted stock agreement, subject to the Reporting Person's continued service to the Issuer as of each vesting date. F4 · shares: 15,000 restricted shares vest on December 31, 2025, subject to the Reporting Person's continued service to the Issuer as of such vesting date. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 21:15 UTC |
Branitzky OronDirector
|
GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-028141 · ownership.xml · nonDerivative · entry 1 Branitzky Oron · CIK 0001714993 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,500 F1 · shares: Restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan. F2 · shares: The restricted shares vest on December 31, 2025, subject to the Reporting Person's continued service to the Issuer as of such vesting date. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 21:15 UTC |
Cembrero Saralegui BorjaChief Growth Officer
|
GrantCommon Stock | 110,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-028146 · ownership.xml · nonDerivative · entry 1 Cembrero Saralegui Borja · CIK 0002067690 · Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,965 F1 · shares: Restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan (the "Plan"). F2 · shares: 10,000 restricted shares vest upon grant date. F3 · shares: 40,000 restricted shares vest in three equal annual installments, with 1/3 vesting on each of January 1, 2026, January 1, 2027 and January 1, 2028, subject to the Reporting Person's continued service to the Issuer as of each vesting date. F4 · shares: Up to 60,000 restricted shares vest upon and subject to achievement of certain profit and business targets as set forth in the restricted stock agreement, subject to the Reporting Person's continued service to the Issuer as of each vesting date. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 21:15 UTC |
Golan RoyDirector
|
GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-028143 · ownership.xml · nonDerivative · entry 1 Golan Roy · CIK 0001999257 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 F1 · shares: Restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan. F2 · shares: The restricted shares vest on December 31, 2025, subject to the Reporting Person's continued service to the Issuer as of such vesting date. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 21:15 UTC |
Kaufman ArikDirector
|
GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-028142 · ownership.xml · nonDerivative · entry 1 Kaufman Arik · CIK 0001713725 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,500 F1 · shares: Restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan. F2 · shares: The restricted shares vest on December 31, 2025, subject to the Reporting Person's continued service to the Issuer as of such vesting date. Read SEC document |
| December 01, 2025 Filed Dec 2, 2025 12:48 UTC |
Luzon RonenDirector · Chief Executive Officer
|
PurchaseCommon Stock | 2,600 | $0.91 | $2,353.00 |
DisclosureSEC source: 0001493152-25-025691 · ownership.xml · nonDerivative · entry 1 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,335 F1 · price: The reported price is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.88 to $0.93 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| November 25, 2025 Filed Nov 26, 2025 11:05 UTC |
Luzon RonenDirector · Chief Executive Officer
|
PurchaseCommon Stock | 14,000 | $0.90 | $12,530.00 |
DisclosureSEC source: 0001493152-25-025078 · ownership.xml · nonDerivative · entry 2 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,735 F2 · price: The reported price is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.83 to $0.96 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| November 24, 2025 Filed Nov 26, 2025 11:05 UTC |
Luzon RonenDirector · Chief Executive Officer
|
PurchaseCommon Stock | 235 | $0.89 | $207.98 |
DisclosureSEC source: 0001493152-25-025078 · ownership.xml · nonDerivative · entry 1 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,735 F1 · price: The reported price is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.88 to $0.89 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| November 20, 2025 Filed Nov 21, 2025 08:55 UTC |
Luzon RonenDirector · Chief Executive Officer
|
PurchaseCommon Stock | 3,000 | $0.77 | $2,310.00 |
DisclosureSEC source: 0001493152-25-024553 · ownership.xml · nonDerivative · entry 2 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,500 Read SEC document |
| November 20, 2025 Filed Nov 21, 2025 08:55 UTC |
Luzon RonenDirector · Chief Executive Officer
|
PurchaseCommon Stock | 10,500 | $0.76 | $7,980.00 |
DisclosureSEC source: 0001493152-25-024553 · ownership.xml · nonDerivative · entry 1 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,500 Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 16:10 UTC |
Elmaliah OrenChief Financial Officer
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 150 | Not disclosed Strike: $1.28 | Not disclosed |
DisclosureSEC source: 0001641172-25-014032 · ownership.xml · derivative · entry 2 Elmaliah Oren · CIK 0001713701 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150 Underlying: Common Stock, $.001 par value per share · 150 shares Expires 2025-08-10 F2 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 16:10 UTC |
Elmaliah OrenChief Financial Officer
|
Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 150 | Not disclosed Strike: $8.72 | Not disclosed |
DisclosureSEC source: 0001641172-25-014032 · ownership.xml · derivative · entry 1 Elmaliah Oren · CIK 0001713701 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 150 shares Expires 2025-08-10 F2 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 16:10 UTC |
Pardo BillyCPO & COO
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 800 | Not disclosed Strike: $1.28 | Not disclosed |
DisclosureSEC source: 0001641172-25-014035 · ownership.xml · derivative · entry 4 Pardo Billy · CIK 0001686858 · CPO & COO 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 800 Underlying: Common Stock, $.001 par value per share · 800 shares Expires 2025-08-10 F2 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. F3 · ownership.nature: Options acquired by Spouse (Chief Executive Officer Ronen Luzon). Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 16:10 UTC |
Pardo BillyCPO & COO
|
Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 800 | Not disclosed Strike: $8.72 | Not disclosed |
DisclosureSEC source: 0001641172-25-014035 · ownership.xml · derivative · entry 3 Pardo Billy · CIK 0001686858 · CPO & COO 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 800 shares Expires 2025-08-10 F2 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. F3 · ownership.nature: Options acquired by Spouse (Chief Executive Officer Ronen Luzon). Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 16:10 UTC |
Pardo BillyCPO & COO
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 650 | Not disclosed Strike: $1.28 | Not disclosed |
DisclosureSEC source: 0001641172-25-014035 · ownership.xml · derivative · entry 2 Pardo Billy · CIK 0001686858 · CPO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 650 Underlying: Common Stock, $.001 par value per share · 650 shares Expires 2025-08-10 F2 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 16:10 UTC |
Pardo BillyCPO & COO
|
Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 650 | Not disclosed Strike: $8.72 | Not disclosed |
DisclosureSEC source: 0001641172-25-014035 · ownership.xml · derivative · entry 1 Pardo Billy · CIK 0001686858 · CPO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 650 shares Expires 2025-08-10 F2 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 16:10 UTC |
Luzon RonenDirector · Chief Executive Officer
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 650 | Not disclosed Strike: $1.28 | Not disclosed |
DisclosureSEC source: 0001641172-25-014034 · ownership.xml · derivative · entry 4 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · see footnote Disclosed balance after: 650 Underlying: Common Stock, $.001 par value per share · 650 shares Expires 2025-08-10 F2 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. F3 · ownership.nature: Options acquired by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo). Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 16:10 UTC |
Luzon RonenDirector · Chief Executive Officer
|
Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 650 | Not disclosed Strike: $8.72 | Not disclosed |
DisclosureSEC source: 0001641172-25-014034 · ownership.xml · derivative · entry 3 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · see footnote Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 650 shares Expires 2025-08-10 F2 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. F3 · ownership.nature: Options acquired by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo). Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 16:10 UTC |
Luzon RonenDirector · Chief Executive Officer
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 800 | Not disclosed Strike: $1.28 | Not disclosed |
DisclosureSEC source: 0001641172-25-014034 · ownership.xml · derivative · entry 2 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 800 Underlying: Common Stock, $.001 par value per share · 800 shares Expires 2025-08-10 F2 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 16:10 UTC |
Luzon RonenDirector · Chief Executive Officer
|
Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 800 | Not disclosed Strike: $8.72 | Not disclosed |
DisclosureSEC source: 0001641172-25-014034 · ownership.xml · derivative · entry 1 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 800 shares Expires 2025-08-10 F2 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 20:10 UTC |
Branitzky OronDirector
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 150 | Not disclosed Strike: $1.28 | Not disclosed |
DisclosureSEC source: 0001641172-25-014030 · ownership.xml · derivative · entry 2 Branitzky Oron · CIK 0001714993 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150 Underlying: Common Stock, $.001 par value per share · 150 shares Expires 2025-08-10 F2 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 20:10 UTC |
Branitzky OronDirector
|
Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 150 | Not disclosed Strike: $8.72 | Not disclosed |
DisclosureSEC source: 0001641172-25-014030 · ownership.xml · derivative · entry 1 Branitzky Oron · CIK 0001714993 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 150 shares Expires 2025-08-10 F2 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 20:10 UTC |
Cembrero Saralegui BorjaChief Growth Officer
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 2,500 | Not disclosed Strike: $1.28 | Not disclosed |
DisclosureSEC source: 0001641172-25-014031 · ownership.xml · derivative · entry 4 Cembrero Saralegui Borja · CIK 0002067690 · Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock, $.001 par value per share · 2,500 shares Expires 2029-02-14 F3 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged. F2 · derivative.exercise_date: The options were granted under the My Size, Inc. 2017 Equity Incentive Plan and vest and become exercisable in three equal installments, with 1/3 vesting on each of February 14, 2025, February 14, 2026 and February 14, 2027, subject to the Reporting Person's continued service. Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 20:10 UTC |
Cembrero Saralegui BorjaChief Growth Officer
|
Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 2,500 | Not disclosed Strike: $3.83 | Not disclosed |
DisclosureSEC source: 0001641172-25-014031 · ownership.xml · derivative · entry 3 Cembrero Saralegui Borja · CIK 0002067690 · Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 2,500 shares Expires 2029-02-14 F3 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged. F2 · derivative.exercise_date: The options were granted under the My Size, Inc. 2017 Equity Incentive Plan and vest and become exercisable in three equal installments, with 1/3 vesting on each of February 14, 2025, February 14, 2026 and February 14, 2027, subject to the Reporting Person's continued service. Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 20:10 UTC |
Cembrero Saralegui BorjaChief Growth Officer
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 1,688 | Not disclosed Strike: $1.28 | Not disclosed |
DisclosureSEC source: 0001641172-25-014031 · ownership.xml · derivative · entry 2 Cembrero Saralegui Borja · CIK 0002067690 · Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,688 Underlying: Common Stock, $.001 par value per share · 1,688 shares Expires 2028-07-13 F3 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: The options were granted under the My Size, Inc. 2017 Equity Incentive Plan and vest and become exercisable in three equal installments, with 1/3 vesting on each of July 13, 2024, July 13, 2025 and July 13, 2026, subject to the Reporting Person's continued service. Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 20:10 UTC |
Cembrero Saralegui BorjaChief Growth Officer
|
Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 1,688 | Not disclosed Strike: $8.72 | Not disclosed |
DisclosureSEC source: 0001641172-25-014031 · ownership.xml · derivative · entry 1 Cembrero Saralegui Borja · CIK 0002067690 · Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 1,688 shares Expires 2028-07-13 F3 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: The options were granted under the My Size, Inc. 2017 Equity Incentive Plan and vest and become exercisable in three equal installments, with 1/3 vesting on each of July 13, 2024, July 13, 2025 and July 13, 2026, subject to the Reporting Person's continued service. Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 20:10 UTC |
Kaufman ArikDirector
|
GrantOption to purchase Common Stock (right to buy) · Derivative | 150 | Not disclosed Strike: $1.28 | Not disclosed |
DisclosureSEC source: 0001641172-25-014033 · ownership.xml · derivative · entry 2 Kaufman Arik · CIK 0001713725 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150 Underlying: Common Stock, $.001 par value per share · 150 shares Expires 2025-08-10 F2 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 20:10 UTC |
Kaufman ArikDirector
|
Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 150 | Not disclosed Strike: $8.72 | Not disclosed |
DisclosureSEC source: 0001641172-25-014033 · ownership.xml · derivative · entry 1 Kaufman Arik · CIK 0001713725 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 150 shares Expires 2025-08-10 F2 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| December 30, 2024 Filed Jan 2, 2025 16:15 UTC |
Pardo BillyCPO & COO
|
SaleCommon Stock | 2,000 | $5.40 | $10,800.00 |
DisclosureSEC source: 0001493152-25-000061 · ownership.xml · nonDerivative · entry 4 Pardo Billy · CIK 0001686858 · CPO & COO 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 44,000 F1 · ownership.nature: Common stock beneficially owned by Spouse (Chief Executive Officer Ronen Luzon) under the My Size, Inc. 2017 Equity Incentive Plan. Read SEC document |
| December 30, 2024 Filed Jan 2, 2025 16:15 UTC |
Pardo BillyCPO & COO
|
SaleCommon Stock | 2,000 | $5.10 | $10,200.00 |
DisclosureSEC source: 0001493152-25-000061 · ownership.xml · nonDerivative · entry 3 Pardo Billy · CIK 0001686858 · CPO & COO 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 46,000 F1 · ownership.nature: Common stock beneficially owned by Spouse (Chief Executive Officer Ronen Luzon) under the My Size, Inc. 2017 Equity Incentive Plan. Read SEC document |
| December 30, 2024 Filed Jan 2, 2025 16:15 UTC |
Pardo BillyCPO & COO
|
SaleCommon Stock | 2,000 | $5.12 | $10,240.00 |
DisclosureSEC source: 0001493152-25-000061 · ownership.xml · nonDerivative · entry 2 Pardo Billy · CIK 0001686858 · CPO & COO 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 48,000 F1 · ownership.nature: Common stock beneficially owned by Spouse (Chief Executive Officer Ronen Luzon) under the My Size, Inc. 2017 Equity Incentive Plan. Read SEC document |
| December 30, 2024 Filed Jan 2, 2025 16:15 UTC |
Pardo BillyCPO & COO
|
SaleCommon Stock | 2,000 | $5.10 | $10,200.00 |
DisclosureSEC source: 0001493152-25-000061 · ownership.xml · nonDerivative · entry 1 Pardo Billy · CIK 0001686858 · CPO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,750 Read SEC document |
| December 30, 2024 Filed Jan 2, 2025 16:15 UTC |
Kles OrChief Financial Officer
|
SaleCommon Stock | 2,000 | $5.40 | $10,800.00 |
DisclosureSEC source: 0001493152-25-000062 · ownership.xml · nonDerivative · entry 1 Kles Or · CIK 0001686316 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,750 Read SEC document |
| December 30, 2024 Filed Jan 2, 2025 16:15 UTC |
Luzon RonenDirector · Chief Executive Officer
|
SaleCommon Stock | 2,000 | $5.10 | $10,200.00 |
DisclosureSEC source: 0001493152-25-000064 · ownership.xml · nonDerivative · entry 4 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 19,750 F1 · ownership.nature: Common stock beneficially owned by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo) under the My Size, Inc. 2017 Equity Incentive Plan. Read SEC document |
| December 30, 2024 Filed Jan 2, 2025 16:15 UTC |
Luzon RonenDirector · Chief Executive Officer
|
SaleCommon Stock | 2,000 | $5.40 | $10,800.00 |
DisclosureSEC source: 0001493152-25-000064 · ownership.xml · nonDerivative · entry 3 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,000 Read SEC document |
| December 30, 2024 Filed Jan 2, 2025 16:15 UTC |
Luzon RonenDirector · Chief Executive Officer
|
SaleCommon Stock | 2,000 | $5.10 | $10,200.00 |
DisclosureSEC source: 0001493152-25-000064 · ownership.xml · nonDerivative · entry 2 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,000 Read SEC document |
| December 30, 2024 Filed Jan 2, 2025 16:15 UTC |
Luzon RonenDirector · Chief Executive Officer
|
SaleCommon Stock | 2,000 | $5.12 | $10,240.00 |
DisclosureSEC source: 0001493152-25-000064 · ownership.xml · nonDerivative · entry 1 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,000 Read SEC document |
| December 30, 2024 Filed Feb 12, 2025 16:34 UTC |
AVATAR SECURITIES, LLC10% owner
|
SaleCommon stock | 100 | $5.48 | $548.00 |
DisclosureSEC source: 0001214659-25-002494 · marketforms-68044.xml · nonDerivative · entry 2 AVATAR SECURITIES, LLC · CIK 0001438956 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,086 Read SEC document |
| December 30, 2024 Filed Feb 12, 2025 16:34 UTC |
AVATAR SECURITIES, LLC10% owner
|
SaleCommon stock | 120,524 | $4.85 | $584,541.40 |
DisclosureSEC source: 0001214659-25-002494 · marketforms-68044.xml · nonDerivative · entry 1 AVATAR SECURITIES, LLC · CIK 0001438956 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,186 F1 · price: Weighted average price. These shares were sold in multiple transactions at prices ranging from $4.47 to $5.42 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 16:20 UTC |
Zimmerman GuyDirector
|
GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-007021 · ownership.xml · nonDerivative · entry 1 Zimmerman Guy · CIK 0001879643 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 F1 · shares: Restricted stock units granted under the My Size, Inc. 2017 Equity Incentive Plan, which vest on January 1, 2025. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 16:20 UTC |
Elmaliah OrenDirector
|
GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-007017 · ownership.xml · nonDerivative · entry 1 Elmaliah Oren · CIK 0001713701 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 F1 · shares: Restricted stock units granted under the My Size, Inc. 2017 Equity Incentive Plan, which vest on January 1, 2025. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 16:20 UTC |
Pardo BillyCPO & COO
|
GrantCommon Stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-007019 · ownership.xml · nonDerivative · entry 2 Pardo Billy · CIK 0001686858 · CPO & COO 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 400,000 F1 · shares: Restricted stock granted under the My Size, Inc. 2017 Equity Incentive Plan, which vests in three equal annual installments, with 1/3 vesting on each of January 1, 2025, January 1, 2026 and January 1, 2027, subject to the Reporting Person continuously providing services to the Issuer as an employee through such vesting date. F2 · ownership.nature: Common stock beneficially owned by Spouse (Chief Executive Officer Ronen Luzon) under the My Size, Inc. 2017 Equity Incentive Plan. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 16:20 UTC |
Pardo BillyCPO & COO
|
GrantCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-007019 · ownership.xml · nonDerivative · entry 1 Pardo Billy · CIK 0001686858 · CPO & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 174,000 F1 · shares: Restricted stock granted under the My Size, Inc. 2017 Equity Incentive Plan, which vests in three equal annual installments, with 1/3 vesting on each of January 1, 2025, January 1, 2026 and January 1, 2027, subject to the Reporting Person continuously providing services to the Issuer as an employee through such vesting date. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 16:20 UTC |
Kles OrChief Financial Officer
|
GrantCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-007015 · ownership.xml · nonDerivative · entry 1 Kles Or · CIK 0001686316 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 174,000 F1 · shares: Restricted stock granted under the My Size, Inc. 2017 Equity Incentive Plan, which vests in three equal annual installments, with 1/3 vesting on each of January 1, 2025, January 1, 2026 and January 1, 2027, subject to the Reporting Person continuously providing services to the Issuer as an employee through such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.